Literature DB >> 24160729

Idiopathic macular telangiectasia type 2 (idiopathic juxtafoveolar retinal telangiectasis type 2A, Mac Tel 2).

Lihteh Wu1, Teodoro Evans, J Fernando Arevalo.   

Abstract

Macular telangiectasia type 2-also known as idiopathic perifoveal telangiectasia and juxtafoveolar retinal telangiectasis type 2A or Mac Tel 2-is an acquired bilateral neurodegenerative macular disease that usually manifests itself during the fourth to sixth decades of life and is characterized by minimal dilatation of the parafoveal capillaries with graying of the retinal area involved, a lack of lipid exudation, right-angled retinal venules, refractile deposits in the superficial retina, hyperplasia of the retinal pigment epithelium, foveal atrophy, and subretinal neovascularization (SRNV). Optical coherence tomography images typically demonstrate intraretinal hyporeflective spaces that are usually not related to retinal thickening or fluorescein leakage. The typical fluorescein angiographic finding is a deep intraretinal hyperfluorescent leakage in the temporal parafoveal area. With time the leakage may involve the whole parafovea, but does not extend to the center of the fovea. Long-term prognosis for central vision is variable and depends on the development of SRNV or macular atrophy. Pathogenesis remains unclear, but Müller cells and macular pigment appear to play a central role. Currently there is no known treatment for the underlying cause of this condition, but treatment of the SRNV may be beneficial.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Idiopathic juxtafoveal telangiectasis; Müller cells; choroidal neovascularization; juxtafoveal retinal telangiectasia; lutein; macular edema; macular pigment; macular telangiectasia (Mac Tel 2); parafoveal telangiectasis; perifoveal telangiectasis; retinal angiomatous proliferation; retinal telangiectasis; subretinal neovascularization; zeaxanthin

Mesh:

Year:  2013        PMID: 24160729     DOI: 10.1016/j.survophthal.2012.11.007

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  20 in total

1.  Comparison of anatomical and visual outcomes following different anti-vascular endothelial growth factor treatments in subretinal neovascular membrane secondary to type 2 proliferative macular telangiectasia.

Authors:  Buğra Karasu; Betul Onal Gunay
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-25       Impact factor: 3.117

2.  The preproliferative stage in type 2 macular telangiectasia (MacTel type 2).

Authors:  Ramesh Venkatesh; Nikitha Gurram Reddy; Pranjal Mishra; Arpitha Pereira; Deepashri Mutalik; Sameeksha Agrawal; Abhishek Bhatt; Naresh Kumar Yadav; Jay Chhablani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-08-19       Impact factor: 3.117

3.  One-year follow-up of optical coherence tomography angiography microvascular findings: macular telangiectasia type 2 versus tamoxifen retinopathy.

Authors:  Yu Jeong Park; Suhwan Lee; Young Hee Yoon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-05-10       Impact factor: 3.535

4.  Retinal vascular density evaluated by optical coherence tomography angiography in macular telangiectasia type 2.

Authors:  Berna Dogan; Muhammet Kazim Erol; Melih Akidan; Elcin Suren; Yusuf Akar
Journal:  Int Ophthalmol       Date:  2019-01-03       Impact factor: 2.031

5.  SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF NEOVASCULAR MACULAR TELANGIECTASIA TYPE 2.

Authors:  Qinqin Zhang; Ruikang K Wang; Chieh-Li Chen; Andrew D Legarreta; Mary K Durbin; Lin An; Utkarsh Sharma; Paul F Stetson; John E Legarreta; Luiz Roisman; Giovanni Gregori; Philip J Rosenfeld
Journal:  Retina       Date:  2015-11       Impact factor: 4.256

6.  Fluorescence Lifetime Imaging Ophthalmoscopy: A Novel Way to Assess Macular Telangiectasia Type 2.

Authors:  Lydia Sauer; Rebekah H Gensure; Martin Hammer; Paul S Bernstein
Journal:  Ophthalmol Retina       Date:  2017-12-08

7.  Microvascular changes precede visible neurodegeneration in fellow eyes of patients with asymmetric type 2 macular telangiectasia.

Authors:  Kiran Chandran; Anantharaman Giridhar; Mahesh Gopalakrishnan; Sobha Sivaprasad
Journal:  Eye (Lond)       Date:  2021-07-29       Impact factor: 4.456

8.  Venovenous anastomosis in macular telangiectasia type 2: an unusual presentation.

Authors:  Avadhesh Oli; Raja Narayanan
Journal:  BMJ Case Rep       Date:  2020-06-30

9.  Bilateral Retinal Vein Occlusion-Simulated Coats' Disease.

Authors:  Rui Hua; Meixia Zhang
Journal:  Diagnostics (Basel)       Date:  2021-05-19

10.  A case of Mac Tel 2 with an unusual sub macular vitelliform lesion.

Authors:  T Lekha; Nikit Sarwate; Renuka Sarwate
Journal:  GMS Ophthalmol Cases       Date:  2015-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.